Taiwan FDA registration dc2935c4d2f0dcc1eea3550827ac0d3e
"Immulab" Celpresol Red Cell Preservation Solution (Non-sterile)
TW: "依免羅" 紅血球保存液 (未滅菌)
Taiwan·Risk Class 1·MD·IMMULAB PTY LTD·Registered Mar 20, 2020 – Mar 20, 2025ExpiredRegistration details
- Analysis ID
- dc2935c4d2f0dcc1eea3550827ac0d3e
- License Form
- Ministry of Health Medical Device Import No. 021386
- Customs Code
- DHA09402138602
Company information
- Manufacturer
- IMMULAB PTY LTD
- Manufacturer Country
- Australia
- Authorized Representative
- GLORY BIOSCIENCE CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of blood cell thinners (B.8200) of the management methods for medical devices.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B8200 Blood cell thinner
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 20, 2020
- Expiry Date
- Mar 20, 2025
About this record
Access comprehensive regulatory information for "Immulab" Celpresol Red Cell Preservation Solution (Non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number dc2935c4d2f0dcc1eea3550827ac0d3e and manufactured by IMMULAB PTY LTD. The authorized representative in Taiwan is GLORY BIOSCIENCE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices